13D Filing: GAMCO Investors and Nutraceutical International Corp (NUTR)

Page 18 of 18

Page 18 of 18 – SEC Filing

JOINT FILING AGREEMENT
In accordance with Rule 13d-1(f) under the securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Entities (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Shares of Nutraceutical International Corporation, and that this Agreement be included as an Exhibit to such joint filing.  This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this June 21, 2017.
MARIO J. GABELLI
GGCP, INC.
MJG ASSOCIATES, INC.
GABELLI FOUNDATION, INC.
MJG-IV LIMITED PARTNERSHIP
By:/s/ David Goldman 
     David Goldman
     Attorney-in-Fact
TETON ADVISORS, INC.
GABELLI FUNDS, LLC
By: /s/ David Goldman
       David Goldman
       General Counsel -Gabelli Funds, LLC
       Counsel-Teton Advisors, Inc.
GAMCO INVESTORS, INC.
By:/s/ Kevin Handwerker 
 Kevin Handwerker
General Counsel & Secretary – GAMCO Investors, Inc.
ASSOCIATED CAPITAL GROUP, INC.
GAMCO ASSET MANAGEMENT INC.
GABELLI & COMPANY INVESTMENT ADVISERS, INC.
G.RESEARCH, INC.
By:/s/ Douglas R. Jamieson
     Douglas R. Jamieson
     President & Chief Executive Officer – Associated Capital Group,
       Inc.
     President – GAMCO Asset Management Inc.
     Vice President – Gabelli & Company Investment Advisers, Inc.
     Secretary – G.research, Inc.
18

Follow Nutraceutical International Corp (NASDAQ:NUTR)

Page 18 of 18